Stockscreener 앱 받기
3.78
1.82%
-0.07
전일 마감가:
$3.85
열려 있는:
$3.89
하루 거래량:
3,199
Relative Volume:
0.24
시가총액:
$69.14M
수익:
-
순이익/손실:
$-12.63M
주가수익비율:
-5.4451
EPS:
-0.6942
순현금흐름:
$-12.18M
1주 성능:
-3.08%
1개월 성능:
+15.60%
6개월 성능:
+0.53%
1년 성능:
+4.13%
1일 변동 폭
$3.7141
$3.89
1주일 범위
$3.51
$4.00
52주 변동 폭
$2.74
$7.28
Genenta Science Spa Adr Stock (GNTA) Company Profile
GNTA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GNTA
Genenta Science Spa Adr
|
3.78 | 71.33M | 0 | -12.63M | -12.18M | -0.6942 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-06-29 | 재개 | ROTH MKM | Buy |
| 2022-07-25 | 개시 | H.C. Wainwright | Buy |
| 2022-01-13 | 개시 | Maxim Group | Buy |
Genenta Science Spa Adr 주식(GNTA)의 최신 뉴스
Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV) and Esperion (ESPR) - The Globe and Mail
Genenta Science stock maintains Buy rating as Temferon shows promise in GBM - Investing.com
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar - GlobeNewswire Inc.
Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa
Genenta secures €20M in mandatory convertible bond deal - Investing.com India
Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa
Genenta secures $21.9 million for cancer drug trial - Investing.com India
Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks
Genenta Science Secures €20 Million Financing to Boost Cancer Therapy Development - TipRanks
Oncology Breakthroughs: How Cancer Research Is Advancing in 202527.02.25News - Ariva
Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance
Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks
Genenta Science Announces Shareholder Meeting - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
10 Best Italian Stocks To Buy Now - Yahoo Finance
Genenta Science Spa Adr (GNTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.37%
자본화:
|
볼륨(24시간):